Haleon, GB00BMX86B70

Haleon wins Thorne bid interest, shares trade on LSE focus

Published on 06/29/2026 at 11:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Haleon is drawing fresh market attention after reports that it has joined the bidding process for Thorne. The shares also trade with analyst context on MarketScreener and recent Reuters coverage of the consumer healthcare group.

Haleon, GB00BMX86B70, Illustration mit AI erstellt.
Haleon, GB00BMX86B70, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 11:43.

Haleon (GB00BMX86B70) is back on the market’s radar in London after reports linked the consumer healthcare group to Thorne. Reuters reported the bid interest, while Haleon shares also trade with a clear analyst backdrop on the FTSE 100.

Reuters puts Thorne in view

Reuters said Haleon has entered the bidding process for Thorne, a dietary supplements maker, as the sales process moves ahead. The report gives the stock a concrete corporate angle and keeps the focus on deal logic rather than headline noise. Reuters UK coverage

MarketScreener currently shows Haleon at 345.95 GBX in London, down 0.67 percent on the day and 3.86 percent higher over five days. The same page lists a median target of 4.136 GBP and a reported gap of 18.76 percent versus that midpoint. MarketScreener consensus snapshot

Analysts keep a lid on it

Analyst commentary has stayed active in June, with JPMorgan reiterating a Sell view on 24 June and Rothschild & Co Redburn cutting the shares to Neutral on 18 June, both cited by MarketScreener. That keeps Haleon inside a cautious research setup even as the Thorne process adds a live corporate storyline. Recent analyst notes on MarketScreener

Go deeper

All news and analysis on the Haleon shares

The Haleon name stays linked to consumer healthcare, while the current debate centers on deal interest, analyst views and the London listing.

How Haleon makes money

Haleon sells consumer health products such as Sensodyne toothpaste, Panadol pain relief and Advil-branded medicines in selected markets. The business model centers on branded over-the-counter healthcare, oral health and vitamins.

London price check

The Haleon shares (GB00BMX86B70) trade on the London market in sterling. MarketScreener showed the stock at 345.95 GBX on 2026-06-29, 11:12 UTC.

Haleon key data

  • Company: Haleon plc
  • ISIN: GB00BMX86B70
  • Ticker: HLN
  • Trading venue: London Stock Exchange
  • Price (as of 2026-06-29, 11:12): 345.95 GBX
  • Market cap: 31.4 billion GBP
  • Sector / industry: Consumer Staples - Household & Personal Products
  • Index membership: FTSE 100

More on the Haleon shares in social media

Disclaimer: This article is for information only and is not investment advice.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | GB00BMX86B70 | HALEON | boerse | 69651928 | bgmi